IRIS Accounts Production v24.2.0.383 04298840 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh042988402023-03-31042988402024-03-31042988402023-04-012024-03-31042988402022-03-31042988402022-04-012023-03-31042988402023-03-3104298840ns15:EnglandWales2023-04-012024-03-3104298840ns14:PoundSterling2023-04-012024-03-3104298840ns10:Director12023-04-012024-03-3104298840ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3104298840ns10:SmallEntities2023-04-012024-03-3104298840ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3104298840ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3104298840ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3104298840ns10:FullAccounts2023-04-012024-03-310429884012023-04-012024-03-3104298840ns5:CurrentFinancialInstruments2024-03-3104298840ns5:CurrentFinancialInstruments2023-03-3104298840ns5:ShareCapital2024-03-3104298840ns5:ShareCapital2023-03-3104298840ns5:RetainedEarningsAccumulatedLosses2024-03-3104298840ns5:RetainedEarningsAccumulatedLosses2023-03-3104298840ns10:RegisteredOffice2023-04-012024-03-3104298840ns5:NetGoodwill2023-04-012024-03-3104298840ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3104298840ns5:LeaseholdImprovements2023-04-012024-03-3104298840ns5:PlantMachinery2023-04-012024-03-3104298840ns5:MotorVehicles2023-04-012024-03-3104298840ns5:NetGoodwill2023-03-3104298840ns5:NetGoodwill2024-03-3104298840ns5:NetGoodwill2023-03-3104298840ns5:LeaseholdImprovements2023-03-3104298840ns5:PlantMachinery2023-03-3104298840ns5:MotorVehicles2023-03-3104298840ns5:LeaseholdImprovements2024-03-3104298840ns5:PlantMachinery2024-03-3104298840ns5:MotorVehicles2024-03-3104298840ns5:LeaseholdImprovements2023-03-3104298840ns5:PlantMachinery2023-03-3104298840ns5:MotorVehicles2023-03-3104298840ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3104298840ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31
REGISTERED NUMBER: 04298840 (England and Wales)
























D & L MEDICAL LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024






D & L MEDICAL LIMITED (REGISTERED NUMBER: 04298840)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024










Page

Balance Sheet 1

Notes to the Financial Statements 3


D & L MEDICAL LIMITED (REGISTERED NUMBER: 04298840)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 135,642 108,358
135,642 108,358

CURRENT ASSETS
Stocks 368,668 485,643
Debtors 6 978,838 311,088
Cash at bank and in hand 632,628 999,017
1,980,134 1,795,748
CREDITORS
Amounts falling due within one year 7 358,044 172,537
NET CURRENT ASSETS 1,622,090 1,623,211
TOTAL ASSETS LESS CURRENT LIABILITIES 1,757,732 1,731,569

PROVISIONS FOR LIABILITIES 34,687 19,861
NET ASSETS 1,723,045 1,711,708

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 1,723,043 1,711,706
1,723,045 1,711,708

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

D & L MEDICAL LIMITED (REGISTERED NUMBER: 04298840)

BALANCE SHEET - continued
31 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 November 2024 and were signed on its behalf by:





L Hood - Director


D & L MEDICAL LIMITED (REGISTERED NUMBER: 04298840)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024


1. STATUTORY INFORMATION

D & L Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 04298840

Registered office: Unit 9 Mead Business Centre
Mead Lane
Hertford
Hertfordshire
SG13 7BJ

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2010, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 15% on cost
Plant and machinery - 20% on cost
Motor vehicles - 25% on cost

Stocks
Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


D & L MEDICAL LIMITED (REGISTERED NUMBER: 04298840)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 15 (2023 - 12 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2023
and 31 March 2024 130,000
AMORTISATION
At 1 April 2023
and 31 March 2024 130,000
NET BOOK VALUE
At 31 March 2024 -
At 31 March 2023 -

D & L MEDICAL LIMITED (REGISTERED NUMBER: 04298840)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


5. TANGIBLE FIXED ASSETS
Improvements
to Plant and Motor
property machinery vehicles Totals
£    £    £    £   
COST
At 1 April 2023 33,691 26,281 274,603 334,575
Additions 40,306 2,912 60,746 103,964
Disposals - - (186,328 ) (186,328 )
At 31 March 2024 73,997 29,193 149,021 252,211
DEPRECIATION
At 1 April 2023 5,054 21,794 199,369 226,217
Charge for year 11,099 1,552 46,655 59,306
Eliminated on disposal - - (168,954 ) (168,954 )
At 31 March 2024 16,153 23,346 77,070 116,569
NET BOOK VALUE
At 31 March 2024 57,844 5,847 71,951 135,642
At 31 March 2023 28,637 4,487 75,234 108,358

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 933,113 296,903
Other debtors 45,725 14,185
978,838 311,088

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Hire purchase contracts - 3,511
Trade creditors 152,286 105,047
Taxation and social security 145,806 7,806
Other creditors 59,952 56,173
358,044 172,537

8. RELATED PARTY DISCLOSURES

During the year, Mr Hood (Director) loaned the company money with no set repayment date. At the year end the amount due to the director from the company was £434 (2023:£752).

9. ULTIMATE CONTROLLING PARTY

The controlling party is L Hood.